Vasculitis & polymyalgia rheumatica

Vascular MRI also depicts musculoskeletal manifestations in giant-cell arteritis–polymyalgia rheumatica spectrum disease patients

Rheumatology (Oxford)Published Retrospective imaging study

Authors' conclusion

Fifty-one percent of the GPSD patients showed signs of inflammation in at least one of the evaluated musculoskeletal structures on contrast-enhanced MRI, with the subscapularis tendon being the most frequently affected.

Study context

Population
Patients with clinically confirmed GCA and PMR (GCA-PMR) spectrum disease (GCA-PMR spectrum disease (GPSD)) with contrast-enhanced T1-weighted VIBE MRI of the torso acquired for aortic vessel wall imaging
Participants
78 patients
Exposure
GCA vs PMR vs GCA-PMR
Outcome
Signs of inflammation in glenohumeral synovium, long biceps and subscapularis tendons, supra-/interspinous ligaments, and shoulder joint effusion on contrast-enhanced vascular MRI
Methodological detailsindependent reading by two experienced radiologists and two inexperienced readers, inter-rater reliability (Fleiss's kappa)
  • Independent reading by two experienced radiologists and two inexperienced readers
  • Inter-rater reliability (Fleiss's kappa)

Main finding

As reported in the abstract

Musculoskeletal inflammation on contrast-enhanced MRI, all patients
Glenohumeral synovitis
35%
Shoulder joint effusion
6%
Long biceps tendon enhancement
26%
Subscapularis tendon enhancement
42%
Supra-/interspinous ligament enhancement
29%

Observational data: associations, not effects.

Further findings

Diagnostic distribution

Inflammatory signs by diagnosis

Patients with PMR showed inflammatory signs at a higher percentage than those with GCA or GCA-PMR

Inter-rater agreement (Fleiss's kappa)

Almost perfect agreement among readers for supra-/interspinous ligament and subscapularis tendon assessments

Original publication

Vascular MRI also depicts musculoskeletal manifestations in giant-cell arteritis–polymyalgia rheumatica spectrum disease patients. Rheumatology (Oxford). Published 25 March 2025. doi:10.1093/rheumatology/keaf169

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.